FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
Today at 5pm ET marks the final deadline for ovarian cancer victims to vote on Johnson & Johnson's (NYSE: JNJ) $8 billion talcum powder settlement. The plan, with a net present value of $6.475 billion, aims to compensate current and future claimants harmed by J&J's talc products. Ovarian cancer claimants are expected to receive $75,000 to $150,000 each on average.
The Ad Hoc Group of Counsel, representing over 77,500 individuals, urges all affected to vote YES, emphasizing that 75% approval is needed. They refute claims by opposing law firms, stating that the settlement offers a fair and timely resolution compared to prolonged litigation. Claimants can vote at www.OfficialTalcClaims.com or by calling 1-888-431-4056.
Oggi alle 17:00 ET scade il termine finale per le vittime di cancro ovarico per votare sull'accordo da 8 miliardi di dollari di Johnson & Johnson (NYSE: JNJ) relativo alla polvere per bambini. Il piano, con un valore attuale netto di 6,475 miliardi di dollari, mira a risarcire i richiedenti attuali e futuri danneggiati dai prodotti a base di talco di J&J. I richiedenti per il cancro ovarico si aspettano di ricevere in media tra $75.000 e $150.000 ciascuno.
Il Gruppo Ad Hoc di Avvocati, che rappresenta oltre 77.500 individui, esorta tutti i coinvolti a votare SÌ, sottolineando che è necessario un approvazione del 75%. Rifiutano le affermazioni degli studi legali avversari, affermando che l'accordo offre una risoluzione equa e tempestiva rispetto a un prolungato contenzioso. I richiedenti possono votare su www.OfficialTalcClaims.com o chiamando il numero 1-888-431-4056.
Hoy a las 5 p.m. ET se marca el plazo final para que las víctimas de cáncer de ovario voten sobre el acuerdo de talco de 8 mil millones de dólares de Johnson & Johnson (NYSE: JNJ). El plan, con un valor presente neto de 6.475 millones de dólares, tiene como objetivo compensar a los reclamantes actuales y futuros dañados por los productos de talco de J&J. Se espera que los reclamantes por cáncer de ovario reciban entre $75,000 y $150,000 cada uno en promedio.
El Grupo Ad Hoc de Abogados, que representa a más de 77,500 personas, insta a todos los afectados a votar SÍ, enfatizando que se necesita una aprobación del 75%. Refutan las afirmaciones de las firmas de abogados opositoras, afirmando que el acuerdo ofrece una resolución justa y oportuna en comparación con un litigio prolongado. Los reclamantes pueden votar en www.OfficialTalcClaims.com o llamando al 1-888-431-4056.
오늘 오후 5시 ET는 난소암 피해자들이 존슨앤드존슨 (NYSE: JNJ)의 80억 달러 탈크 파우더 합의안에 투표할 수 있는 최종 기한으로 설정되어 있습니다. 현재 가치는 64억 7,500만 달러인 이 계획은 J&J의 탈크 제품으로 피해를 본 현재와 미래의 청구인들에게 보상하기 위한 것입니다. 난소암 청구인들은 평균적으로 각각 $75,000에서 $150,000을 받을 것으로 예상됩니다.
77,500명 이상의 개인을 대표하는 귀무효 그룹은 모든 영향을 받은 사람들에게 YES에 투표할 것을 촉구하며, 75%의 승인이 필요하다고 강조하고 있습니다. 그들은 상대 법률 사무소의 주장을 반박하며, 이 합의안이 장기 소송에 비해 공정하고 시의적절한 해결책을 제공한다고 주장합니다. 청구인들은 www.OfficialTalcClaims.com에서 투표하거나 1-888-431-4056으로 전화하여 투표할 수 있습니다.
Aujourd'hui à 17h00 ET marque la date limite finale pour que les victimes du cancer de l'ovaire votent sur le règlement de 8 milliards de dollars de Johnson & Johnson (NYSE: JNJ) concernant la poudre pour bébé. Le plan, d'une valeur actuelle nette de 6,475 milliards de dollars, vise à indemniser les demandeurs actuels et futurs ayant subi des dommages causés par les produits à base de talc de J&J. Les demandeurs atteints de cancer de l'ovaire devraient recevoir en moyenne entre 75 000 et 150 000 dollars chacun.
Le Groupe Ad Hoc d'Avocats, représentant plus de 77 500 personnes, exhorte tous les concernés à voter OUI, en soulignant qu'une approbation de 75 % est nécessaire. Ils réfutent les affirmations des cabinets d'avocats opposés, déclarant que le règlement offre une résolution juste et rapide par rapport à un litige prolongé. Les demandeurs peuvent voter sur www.OfficialTalcClaims.com ou en appelant le 1-888-431-4056.
Heute um 17 Uhr ET endet die Frist für die Opfer von Eierstockkrebs, um über den 8-Milliarden-Dollar-Talkum-Puder-Vergleich von Johnson & Johnson (NYSE: JNJ) abzustimmen. Der Plan hat einen Barwert von 6,475 Milliarden Dollar und zielt darauf ab, aktuelle und zukünftige Anspruchsteller zu entschädigen, die durch die Talkprodukte von J&J geschädigt wurden. Von den Anspruchstellern für Eierstockkrebs wird erwartet, dass sie im Durchschnitt zwischen 75.000 und 150.000 Dollar erhalten.
Die Ad-Hoc-Gruppe der Anwälte, die über 77.500 Personen vertreten, fordert alle Betroffenen auf, mit JA zu stimmen und betont, dass eine Zustimmung von 75% erforderlich ist. Sie weisen die Behauptungen gegnerischer Anwaltskanzleien zurück und erklären, dass der Vergleich eine faire und zeitnahe Lösung im Vergleich zu langwierigen Rechtsstreitigkeiten bietet. Anspruchsteller können auf www.OfficialTalcClaims.com abstimmen oder die Nummer 1-888-431-4056 anrufen.
- J&J offering approximately $8 billion settlement for talcum powder claims
- Ovarian cancer claimants expected to receive $75,000 to $150,000 each on average
- Settlement aims to compensate both current and future claimants
- Potential legal liability for J&J related to talcum powder products
- Risk of settlement not being approved if 75% approval threshold is not met
- Possibility of continued litigation and associated costs if settlement fails
This news is highly significant for Johnson & Johnson and the thousands of claimants involved in the talcum powder litigation. The approximately $8 billion settlement plan, with a net present value of
Several key points stand out:
- The settlement aims to compensate both current and future claimants, with ovarian cancer victims expected to receive between
$75,000 and$150,000 on average. - The voting process requires a
75% approval rate from claimants, highlighting the importance of participation. - The Ad Hoc Group of Counsel, representing over 77,500 individuals, strongly supports the settlement, citing the lengthy litigation process and low success rate in individual trials.
- Opposing law firms' arguments against the settlement are addressed, revealing potential conflicts of interest related to legal fees.
From a legal perspective, this settlement could set a precedent for how large corporations handle mass tort liabilities. The inclusion of future claimants in the settlement structure is particularly noteworthy, as it addresses long-term liability concerns. However, the use of bankruptcy as a resolution mechanism for mass torts remains controversial and could face scrutiny in future cases.
The tight deadline and last-minute push for 'yes' votes suggest a critical juncture in the settlement process. If approved, this could mark a significant shift in how such large-scale product liability cases are resolved, potentially influencing future corporate strategies and legal approaches in similar situations.
The impending deadline for J&J's talc settlement vote carries substantial financial implications. The $8 billion settlement, with a net present value of
Key financial considerations include:
- The settlement's impact on J&J's balance sheet and future cash flows
- Potential effects on investor confidence and stock performance
- Long-term financial benefits of resolving this lingering liability
While the settlement amount is substantial, it provides financial clarity and caps J&J's liability exposure. This could be viewed positively by investors, as it removes a major source of uncertainty. However, the immediate financial impact may be tempered by J&J's strong balance sheet and diverse revenue streams.
It's worth noting that J&J's stock performance has remained relatively stable despite this ongoing litigation, suggesting that the market has largely priced in the expected settlement costs. The resolution of this issue could allow management to refocus on core business strategies and growth initiatives, potentially driving long-term shareholder value.
Investors should monitor the voting outcome closely, as it will significantly influence J&J's financial outlook and legal risk profile going forward. A successful settlement could pave the way for improved market sentiment and potentially lead to a re-rating of the stock.
The J&J talc settlement brings to light critical issues at the intersection of consumer products and public health. From a medical research perspective, several points warrant attention:
- The link between talcum powder use and ovarian cancer remains a subject of ongoing scientific debate.
- Long-term health effects of talc exposure highlight the need for rigorous safety testing of consumer products.
- The settlement's provision for future claimants acknowledges the potential for delayed onset of related health issues.
This case underscores the importance of post-market surveillance and long-term safety studies for widely used consumer products. The scientific community continues to investigate the potential carcinogenic effects of talc, with some studies suggesting a modest increase in ovarian cancer risk associated with perineal talc use.
The settlement's structure, accommodating both current and future claimants, reflects an understanding of the complex nature of cancer development and the potential for long latency periods between exposure and disease onset. This approach could set a precedent for how other product liability cases involving long-term health effects are handled.
Moving forward, this case may spur increased funding and focus on research into the safety of common household products and their long-term health impacts. It also highlights the need for clear communication of potential risks to consumers, even when scientific consensus is not fully established.
For the medical community, this settlement emphasizes the importance of thorough patient history-taking, including exposure to common household products, when assessing cancer risk factors.
Those Who Previously Voted “No” Can Still Switch Their Vote to “Yes”
![Haven't voted in favor of the talcum powder plan yet? There's still time. (Graphic: Business Wire)](https://mms.businesswire.com/media/20240726806059/en/2197556/4/gotnoGgA.jpg)
Haven't voted in favor of the talcum powder plan yet? There's still time. (Graphic: Business Wire)
Talc claimants can vote on the plan at www.OfficialTalcClaims.com or by calling 1-888-431-4056.
The approximately
In order for claimants and families to achieve the timely and fair compensation they deserve, at least
The Ad Hoc Group of Counsel – representing more than 77,500 individuals in this matter – urges all individuals harmed by J&J baby powder products and their attorneys to take action now before the deadline of 5pm ET today.
If you have already voted “no” and are having second thoughts, it’s not too late: Only your latest vote counts and will override any prior vote you cast. Please know that your voting decision is completely confidential.
The Ad Hoc Group of Counsel believes that law firms opposing the settlement have attempted to sway voters towards continued litigation, because doing so would result in hundreds of millions of dollars in fees to the lawyers. Those extra payments to attorneys would not be available through a bankruptcy settlement.
At this critical time, the Ad Hoc Group of Counsel is providing detailed responses to the misleading claims put forth by opposing law firms so that all J&J claimants can make an informed voting decision.
-
What They Claim: There is no way of knowing how much claimants will be paid or when.
The Truth: Under the J&J bankruptcy plan, ovarian cancer claimants are projected to receive an average recovery of between and$75,000 .$150,000
-
What They Claim: Claimants are being deprived of the right to choose to settle.
The Truth: By voting on J&J’s bankruptcy plan, people are actually making their voice heard and preserving their ability to participate in this historic settlement of approximately through a process that eliminates litigation risk.$8 billion
-
What They Claim: Claimants have a better chance of succeeding if they vote “no” and take their case to trial.
The Truth: In over a decade of litigation, just 17 ovarian cancer cases have gone to trial. J&J and its subsidiaries have prevailed in 16 of those cases, with plaintiffs recovering no money.
-
What They Claim: Resolution through multidistrict litigation (MDL) is the fairest way to handle these cases.
The Truth: The law firms opposing the settlement have had ample time to reach a resolution through MDL, but their efforts to reach a consensus have not been successful.
-
What They Claim: There are thousands of “fantasy cases” among those voting to support the plan.
The Truth: Our clients are real people who have suffered greatly as a result of using J&J talc products. This statement is deeply offensive to the tens of thousands of talc victims represented by the Ad Hoc Group of Counsel.
-
What They Claim: People diagnosed with ovarian cancer in the future due to their past use of talc products won't be able to hold J&J accountable.
The Truth: A future claims representative is representing the rights of future claimants, and those future victims will have the same recovery rights as current claimants.
-
What They Claim: Voting against the plan will make J&J suffer.
The Truth: Voting “no” hurts victims, not J&J. If the proposed plan fails to garner enough “yes” votes, these victims will not receive compensation for their suffering for years, if ever.
-
What They Claim: If J&J is able to resolve this matter through bankruptcy, other corporations will also seek to escape mass tort liability and jury trials through the bankruptcy process.
The Truth: If this vote succeeds, J&J will be paying an historic amount - approximately - to settle claims. The company is being held accountable for the harm its products caused.$8 billion
Ovarian cancer survivor Tamika Evans, 47, of
As Anna Maria Sanderford, 61, of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240726806059/en/
Docket Communications
talc@docketcommunications.com
Source: Ad Hoc Group of Counsel
FAQ
What is the deadline for voting on the J&J talc settlement?
How much is J&J offering in the talcum powder settlement?
How much compensation can ovarian cancer claimants expect from the JNJ talc settlement?